Clearbridge 1H3

SGD 0.001 +0.00% +0.00 Updated 16 Nov 2026, 09:14 SGT

Company profile

The business, the people and the ownership behind Clearbridge.

Business overview

About the company

Clearbridge Health is a healthcare group with operations across Asia. Its business includes medical centres and clinics, supported by other healthcare-related business units serving demand for medical services in the region.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-07. PDF p. 3

Listed security

Company & listing

Full Company Name
CLEARBRIDGE HEALTH LIMITED
Trading Currency
SGD
Website
www.clearbridgehealth.com
Listing
Listed on 18 December 2017 on Catalist
ISIN Code
SG1EB6000000

Board & management

Leadership

The report-date Board has four directors. Two executive officers are listed. Former Chairman ChenJohnson is separately identified; he ceased as a director on27February2026.

YeePinhJeremy ceased as CEO and became a non-executive non-independent director on3April2026. The report states that the CEO vacancy is under Board review, while existing key management oversees interim operations. No separate Chairman position had been created following ChenJohnson’s departure.

YEE PINH JEREMY

Non-Executive Non-Independent Director

Board role from 3 April 2026; former Executive Director and CEO during FY2025

ANDREW JOHN LORD

Lead Independent Director

Current Board; Remuneration Committee Chairman; Nominating/Audit Committee Member

MARK BENEDICT RYAN

Independent Director

Current Board; Audit Committee Chairman; Remuneration Committee Member

MAH HOW SOON (MA HAOSHUN)

Independent Director

Current Board; Nominating Committee Chairman; Audit/Remuneration Committee Member

Chen Johnson

Non-Executive Non-Independent Chairman

Former Board Chairman during FY2025; ceased as Director on27February2026

SIMON HOO KIA WEI

Chief Business Officer

Executive Officers; strategic planning, business monitoring and subsidiary operations in Asia Pacific

TAN WEI CHEE

Financial Controller

Executive Officers; Group financial strategy/management, tax and regulatory compliance

Roles listed in ANNUAL REPORT 2025; current appointments are not independently verified.

Holdings

Ownership

Four substantial holders direct/deemed and20registered/depository holders retained as12March2026; Bonvestsdeemed607,862,467 represents100%heldCoop subsidiary, notextraordinaryshares beyondCoopdirectholding.

Top20nominees do not implybeneficialownership. PrintedregistercapitalS$125,666,971.7526 and4,295,820,825fullshares are laterthan31December2025BS, dates/units retained separately.

OriginalTop20subtotal65.99% differs from direct2,835,627,523/4,295,820,825 percentage66.01%; sourcefigurekeptwithqualification; exactsumofprintedindividualpercentages independentlychecked.

Chen Johnson

Direct interest: 234,755,361 shares (5.46%); deemed interest: – shares (–%).

Substantial shareholders as recorded in the Register of Substantial Shareholders

Yee Pinh Jeremy

Direct interest: 244,346,153 shares (5.69%); deemed interest: – shares (–%).

Substantial shareholders as recorded in the Register of Substantial Shareholders

Coop International Pte. Ltd.

Direct interest: 607,862,467 shares (14.15%); deemed interest: – shares (–%).

Substantial shareholders as recorded in the Register of Substantial Shareholders

Bonvests Holdings Limited(1)

Direct interest: – shares (–%); deemed interest: 607,862,467 shares (14.15%).

Substantial shareholders as recorded in the Register of Substantial Shareholders

Number of issued shares

4,295,820,825 ordinary shares; nil treasury shares; nil subsidiary holdings; one vote per share; issued and paid-up share capital S$125,666,971.7526

Shareholder register as at12March2026; separate from31December2025financialbalance date

TOTAL

65.99%Total interest

2,835,627,523 shares
Shareholder register as at12March2026; separate from31December2025financialbalance date

SHAREHOLDING HELD IN THE HANDS OF PUBLIC

68.92%

Shareholder register as at12March2026; separate from31December2025financialbalance date

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Registered & depository holders 20 holders

Registered holdings, including nominees and depositories; these do not establish ultimate beneficial ownership. As reported at 2026-03-12 · PDF p. 186

Registered holderInterestShares / unitsSource
COOP INTERNATIONAL PTE LTD607,862,467 shares; 14.15%.PDF p. 1862026-03-12
DBS NOMINEES PTE LTD423,779,871 shares; 9.86%.PDF p. 1862026-03-12
UOB KAY HIAN PTE LTD261,036,600 shares; 6.08%.PDF p. 1862026-03-12
PHILLIP SECURITIES PTE LTD185,230,824 shares; 4.31%.PDF p. 1862026-03-12
HSBC (SINGAPORE) NOMINEES PTE LTD166,832,500 shares; 3.88%.PDF p. 1862026-03-12
CITIBANK NOMINEES SINGAPORE PTE LTD166,226,862 shares; 3.87%.PDF p. 1862026-03-12
LEE JINTAO100,000,000 shares; 2.33%.PDF p. 1862026-03-12
MAYBANK SECURITIES PTE. LTD.95,004,000 shares; 2.21%.PDF p. 1862026-03-12
LEE MOH MING93,269,601 shares; 2.17%.PDF p. 1862026-03-12
CHNG KIAT LENG86,064,340 shares; 2.00%.PDF p. 1862026-03-12
RAMESH S/O PRITAMDAS CHANDIRAMANI85,000,000 shares; 1.98%.PDF p. 1862026-03-12
SIMON HOO KIA WEI83,514,222 shares; 1.94%.PDF p. 1862026-03-12
CHEN JOHNSON80,795,161 shares; 1.88%.PDF p. 1862026-03-12
OCBC SECURITIES PRIVATE LTD78,598,150 shares; 1.83%.PDF p. 1862026-03-12
TAY KUAN HUAT64,516,129 shares; 1.50%.PDF p. 1862026-03-12
TAN WEIREN VINCENT (CHEN WEIREN VINCENT)60,000,000 shares; 1.40%.PDF p. 1862026-03-12
ASDEW ACQUISITIONS PTE LTD55,000,000 shares; 1.28%.PDF p. 1862026-03-12
LEONG HEE KUAN52,609,896 shares; 1.22%.PDF p. 1862026-03-12
MOOMOO FINANCIAL SINGAPORE PTE. LTD.46,286,900 shares; 1.08%.PDF p. 1862026-03-12
TAN KONG LUEN44,000,000 shares; 1.02%.PDF p. 1862026-03-12

Group structure

Main operating subsidiaries

The table has30holding-path rows covering28distinct legal entities. RedDotHealthTechnology appears under its current and former parent after a transfer; PT Clearbridge Health Indonesia has separate5%and95%holding paths.

Both immediate-parent and effective Group ownership percentages for2025and2024 are disclosed. Two entities were struck off, and three were incorporated during2025. Dates, activities, countries and auditor footnotes are retained.

Clearbridge Australia’s Group ownership is printed as100%for2025and80.20%for2024. Clearbridge Distribution and LKDS(Simei) have Group interests of80.20%and40.90%respectively in both years.

CompanyMarketOwnership interest
Clearbridge BSA Pte. Ltd.Subsidiary holding path; held by CompanyPDF p. 141 Country: Singapore; activities: Investment holding; parent2025: 100%; parent2024: 100%; Group2025: 100%; Group2024: 100%
Clearbridge Assays Pte. Ltd.Subsidiary holding path; held by CompanyPDF p. 141 Country: Singapore; activities: Investment holding; parent2025: 100%; parent2024: 100%; Group2025: 100%; Group2024: 100%
Clearbridge Medical Group Pte. Ltd.Subsidiary holding path; held by CompanyPDF p. 141 Country: Singapore; activities: Clinics/centres and other general medicine services; parent2025: 80.20%; parent2024: 80.20%; Group2025: 80.20%; Group2024: 80.20%
CellTrust Bio Singapore Pte. Ltd.Subsidiary holding path; held by CompanyPDF p. 142 Country: Singapore; activities: Investment holding; parent2025: 100%; parent2024: –%; Group2025: 100%; Group2024: –%
Clearbridge Medical Hong Kong Corporation LimitedSubsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Hong Kong; activities: Biotechnology and life sciences; parent2025: 100%; parent2024: 100%; Group2025: 80.20%; Group2024: 80.20%
Clearbridge Health (Philippines) Inc.Subsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Philippines; activities: Clinics/centres and other general medical services; parent2025: 99.99%; parent2024: 99.99%; Group2025: 80.19%; Group2024: 80.19%
Clearbridge Medica Sdn. Bhd.Subsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Singapore; activities: Clinics/centres and other general medical services; parent2025: –%; parent2024: 100%; Group2025: –%; Group2024: 80.20%
Clearbridge Lifestyle Pte. Ltd.Subsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Singapore; activities: Management consultancy for healthcare organisation; parent2025: 100%; parent2024: 100%; Group2025: 80.20%; Group2024: 80.20%
Clearbridge Distribution Pte. Ltd.Subsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Singapore; activities: Wholesale of medicinal and pharmaceutical products; parent2025: 100%; parent2024: 100%; Group2025: 80.20%; Group2024: 80.20%
Clearbridge Australia Pty. Ltd.Subsidiary holding path; held by Clearbridge Medical Group Pte. Ltd.PDF p. 142 Country: Australia; activities: Dormant; parent2025: 100%; parent2024: 100%; Group2025: 100%; Group2024: 80.20%
Clearbridge Medical Philippines, Inc.Subsidiary holding path; held by Clearbridge Health (Philippines) Inc.PDF p. 143 Country: Philippines; activities: Clinics/centres and other general medical services; parent2025: 65%; parent2024: 65%; Group2025: 52.13%; Group2024: 52.13%
RedDot Holding Co. Limited.Subsidiary holding path; held by CellTrust Bio Singapore Pte. Ltd.PDF p. 143 Country: Hong Kong; activities: Provision of marketing services; parent2025: 100%; parent2024: –%; Group2025: 100%; Group2024: –%
Cell Entrust Bio Co. LimitedSubsidiary holding path; held by CellTrust Bio Singapore Pte. Ltd.PDF p. 143 Country: Hong Kong; activities: Cryopreservation biotechnology; parent2025: 100%; parent2024: –%; Group2025: 100%; Group2024: –%
Shanghai Kai Zhun Health Management Co. Ltd.Subsidiary holding path; held by Clearbridge Medical Hong Kong Corporation LimitedPDF p. 143 Country: China; activities: Distribution of medical devices and related services; parent2025: 100%; parent2024: 100%; Group2025: 80.20%; Group2024: 80.20%
Red Dot Health Technology (Shanghai) Co. Ltd.Subsidiary holding path; held by Clearbridge Medical Hong Kong Corporation LimitedPDF p. 143 Country: China; activities: Distribution of medical and lifestyle products; parent2025: 100%; parent2024: –%; Group2025: 80.20%; Group2024: 80.20%
Clearbridge Dental Holdings Pte. Ltd.Subsidiary holding path; held by Clearbridge Lifestyle Pte. Ltd.PDF p. 143 Country: Singapore; activities: Investment holding; parent2025: 51%; parent2024: 51%; Group2025: 40.90%; Group2024: 40.90%
Red Dot Health Technology (Shanghai) Co. Ltd.Subsidiary holding path; held by Shanghai Kai Zhun Health Management Co. Ltd.PDF p. 143 Country: China; activities: Distribution of medical and lifestyle products; parent2025: –%; parent2024: 100%; Group2025: 80.20%; Group2024: 80.20%
Renum Distribution Holdings Pte. Ltd.Subsidiary holding path; held by Clearbridge Assays Pte. Ltd.PDF p. 144 Country: Singapore; activities: Wholesale of medicinal and pharmaceutical products; parent2025: 100%; parent2024: 100%; Group2025: 100%; Group2024: 100%
PT Clearbridge Health IndonesiaSubsidiary holding path; held by Clearbridge Assays Pte. Ltd.PDF p. 144 Country: Indonesia; activities: Dormant; parent2025: 5%; parent2024: 5%; Group2025: 5%; Group2024: 5%
PT Clearbridge Health IndonesiaSubsidiary holding path; held by Renum Distribution Holdings Pte. Ltd.PDF p. 144 Country: Indonesia; activities: Dormant; parent2025: 95%; parent2024: 95%; Group2025: 95%; Group2024: 95%
PT Clearbridge Medical IndonesiaSubsidiary holding path; held by PT Clearbridge Health IndonesiaPDF p. 144 Country: Indonesia; activities: Dormant; parent2025: –%; parent2024: 49%; Group2025: –%; Group2024: 49%
Dental Town (AMK) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 144 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
LKDS (Hougang Green) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 144 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
LKDS (Simei) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 144 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
LKDS (Yishun) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 144 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
Urban Dental (SG) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 144 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
Dental Focus (Bendemeer) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 145 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
Dental Focus (Pioneer) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 145 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
Dentalfamily (Pioneer) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 145 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%
Dental Focus (People’s Park) Pte. Ltd.Subsidiary holding path; held by Clearbridge Dental Holdings Pte. Ltd.PDF p. 145 Country: Singapore; activities: Provision of dental and ancillary services; parent2025: 100%; parent2024: 100%; Group2025: 40.90%; Group2024: 40.90%

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
SIMON HOO KIA WEI Chief Business Officer PDF p. 16
TAN WEI CHEE Financial Controller PDF p. 16
Lin Moi Heyang Company Secretary As at 8 April 2026 PDF p. 191

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Issued and paid-up share capital S$125,666,971.7526 as at 12 March 2026 · As at 2026-03-12 PDF p. 186
Number of issued shares 4,295,820,825 shares as at 12 March 2026 · As at 2026-03-12 PDF p. 186
Class of shares Ordinary shares as at 12 March 2026 · As at 2026-03-12 PDF p. 186
Voting rights on a poll One vote per share as at 12 March 2026 · As at 2026-03-12 PDF p. 186

Treasury shares

ItemValuePeriod / scopeSource
Number and percentage of treasury shares Nil as at 12 March 2026 · As at 2026-03-12 PDF p. 186
Number and percentage of subsidiary holdings Nil as at 12 March 2026 · As at 2026-03-12 PDF p. 186

Free float

ItemValuePeriod / scopeSource
Shareholding held in the hands of public approximately 68.92% as at 12 March 2026 · As at 2026-03-12 PDF p. 186

Shareholding distribution

ItemValuePeriod / scopeSource
TOTAL 2,071 shareholders Total shareholders; 100.00% of holders; 4,295,820,825 shares, 100.00% · As at 2026-03-12 PDF p. 186
1 – 99 3 holders; 0.14% of holders; 183 shares; 0.00% of shares Size of shareholdings band · As at 2026-03-12 PDF p. 186
100 – 1,000 67 holders; 3.24% of holders; 37,415 shares; 0.00% of shares Size of shareholdings band · As at 2026-03-12 PDF p. 186
1,001 – 10,000 357 holders; 17.24% of holders; 2,495,100 shares; 0.06% of shares Size of shareholdings band · As at 2026-03-12 PDF p. 186
10,001 – 1,000,000 1,405 holders; 67.84% of holders; 247,482,473 shares; 5.76% of shares Size of shareholdings band · As at 2026-03-12 PDF p. 186
1,000,001 and above 239 holders; 11.54% of holders; 4,045,805,654 shares; 94.18% of shares Size of shareholdings band · As at 2026-03-12 PDF p. 186

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Interested Person Transactions (“IPTs”) There were no disclosable IPTs during FY2025. Group, FY2025 PDF p. 83
Compensation of directors and key management personnel 1,089 S$'000 Group, 2025 (2024: 1,155 re-presented) PDF p. 164

Director remuneration

ItemValuePeriod / scopeSource
Yee Pinh Jeremy 530 S$'000 FY2025, Total (S$'000) PDF p. 70
Chen Johnson 60 S$'000 FY2025, Total (S$'000) PDF p. 70
Andrew John Lord 30 S$'000 FY2025, Total (S$'000) PDF p. 70
Mark Benedict Ryan 30 S$'000 FY2025, Total (S$'000) PDF p. 70
Mah How Soon (Ma Haoshun) 30 S$'000 FY2025, Total (S$'000) PDF p. 70

Subsequent events

ItemValuePeriod / scopeSource
Cessation of CEO On 3 April 2026, Mr Yee Pinh Jeremy ceased to be the CEO of the Company and has been redesignated as Non-Executive Non-Independent Director of the Company. Company · As at 2026-04-03 PDF p. 70

Outlook

ItemValuePeriod / scopeSource
Letter from the Board - pull quote We will continue to proactively evaluate our options and opportunities to preserve value for the Group and if need be, undertake certain corporate exercises to restructure our businesses and operations to achieve sustainability and to better position the Group for the future. Group PDF p. 8

Extracted from ANNUAL REPORT 2025 and checked against the cited pages; see the original report for full context.

Source: ANNUAL REPORT 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
19 Jan 2010
Telephone
65 62510136
Fax
65 62510132
Registered Office
37 Jalan Pemimpin
#08-05 Mapex
Singapore 577177
Secretary
Lin Moi Heyang
Tang Pei Chan
Registrar / Transfer Agent
TRICOR BARBINDER SHARE REGISTRATION SERVICES
Registrar Address
9 Raffles Place, Republic Plaza Tower I #26-01, Singapore 048619
Auditors
CLA GLOBAL TS PUBLIC ACCOUNTING CORPORATION
Other Stock Exchange Listings
*SINGAPORE EXCHANGE (CATALIST)
Country
SINGAPORE
Security Type
stocks